Home › Migraine › District of Columbia
Migraine clinical trials in District of Columbia
5 studies for Migraine are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Velocity Clinical Research, Washington DC, Washington D.C.
RecruitingPhase 1
Ages 6 to 11 · All sexes · Updated Sep 28, 2026 · NCT06995729Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Velocity Clinical Research, Washington DC, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 28, 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's National Medical Center, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 24, 2026 · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Emerson Clinical Research Institute - Connecticut Avenue - Washington /ID# 231693, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.